Prenatal therapy of everolimus for large fetal cardiac rhabdomyoma in tuberous sclerosis
Annals of Pediatric Cardiology · 2026-03 · 19 (2) · 231-233
DOI: 10.4103/apc.apc_237_25 ↗Kurz gefasst
Fallbericht in der Zeitschrift Annals of Pediatric Cardiology, online erschienen am 25.05.2026. Verfasst von Shweta Bakhru und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Cardiology, Rainbow Children's Heart Institute, Hyderabad, Telangana, India. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 5 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Fetal cardiac rhabdomyoma is the most common prenatal cardiac tumor and is frequently associated with tuberous sclerosis complex (TSC). Everolimus, a mammalian target of rapamycin inhibitor, is an established postnatal therapy for TSC-related tumors, but its prenatal use remains rare. A 27-year-old primigravida was referred at 21 weeks’ gestation for evaluation of a left ventricular mass. Given the rapid, severe progression of tumor size, maternal oral everolimus therapy was initiated at 28 weeks, with dose titration to achieve drug levels of 3–8 ng/ml. At 32 weeks, the tumor size regressed significantly. Neonatal serum everolimus on day 1 was 5.2 ng/mL, confirming transplacental transfer. Therapy was resumed postnatally, and at 5 months, the tumor had completely resolved, with normal neurodevelopment and no seizures. While short-term safety and efficacy of prenatal everolimus therapy are promising, further studies are needed to establish standardized dosing, safety profiles, and long-term developmental outcomes.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatric Cardiology, Rainbow Children's Heart Institute, Hyderabad, Telangana, India.
- Department of Fetal Medicine, Rainbow Children's Institute, Hyderabad, Telangana, India.
- Department of Gynecology and Obstetrics, Rainbow Children's Hospital and Birth Right Center, Hyderabad, Telangana, India.
Zitieren
APA
Bakhru, S., Koneti, N. R., Gayatri, V., & Golla, S. S. (2026). Prenatal therapy of everolimus for large fetal cardiac rhabdomyoma in tuberous sclerosis. Annals of Pediatric Cardiology, 19(2), 231-233. https://doi.org/10.4103/apc.apc_237_25
Vancouver
Bakhru S, Koneti NR, Gayatri V, Golla SS. Prenatal therapy of everolimus for large fetal cardiac rhabdomyoma in tuberous sclerosis. Annals of Pediatric Cardiology. 2026;19(2):231-233. doi:10.4103/apc.apc_237_25
BibTeX
@article{Bakhru2026,
author = {Bakhru, Shweta and Koneti, Nageswara Rao and Gayatri, V and Golla, Sneha Santi},
title = {Prenatal therapy of everolimus for large fetal cardiac rhabdomyoma in tuberous sclerosis},
journal = {Annals of Pediatric Cardiology},
year = {2026},
volume = {19},
number = {2},
pages = {231--233},
doi = {10.4103/apc.apc_237_25}
}
EUVIMED